Genome-Wide Prediction of Vaccine Candidates for Leishmania major: An Integrated Approach

Table 6

The distribution of fractional immunogenicity for the 34 optimal epitopes against the population of South America.

S. number	Epitope	Fraction of overall immunogenicity	Covered alleles
1	SLWSLLAGV	0.1	A0201
2	ALYTSIPVR	0.1	A3101
3	GYPNINTYL	0.08	A2402 Cw0401
4	YLLDGDQLI	0.08	A0201
5	LYLLLPFLL	0.08	A2402 Cw0401
6	GYIVVDKYF	0.05	A2402
7	VLVGVVLGV	0.05	A0201
8	TLFPIDVTV	0.04	A0201
9	SFDDYTMVL	0.04	A2402 B3901 Cw0401
10	VSAQTIDDY	0.04	Cw0702
11	SPTPLLAAL	0.03	Cw0401 Cw0702
12	LMAAMLVAV	0.03	A0201
13	FLFSPTDTL	0.03	A0201
14	HVARQLASY	0.03	Cw0702
15	MLPDMTCSL	0.02	A0201
16	LFLLVIYAF	0.02	A2402 Cw0401
17	LFGAFLFAF	0.02	Cw0401 Cw0702
18	AYFVVPLEM	0.02	A2402
19	KHLLMAAML	0.02	B3901
20	IHPERTVAL	0.02	B3901
21	LPRLFLAFL	0.02	Cw0401
22	TPRIPLDSL	0.01	Cw0401
23	LVHAGIAGK	0.01	A6801
24	AHAPQNAAL	0.01	B3901
25	APNYYLTPL	0.01	Cw0401
26	SVVDPMQNY	0.01	Cw0702
27	AMKDPYTNY	0.01	Cw0702
28	YLCDRTTAA	0.01	A0201
29	LLPRLFLAF	0.01	B1501
30	SQQETSSLY	0.01	B1501
31	YQLTGTPVL	<0.01	B5201
32	VRAPFTIQL	<0.01	B3901
33	KRGAAAVLL	<0.01	B3901
34	SIMSLQIRY	<0.01	B1501